FDA accepts priority review for Merck’s antibiotic combo Recarbrio

Infections caused by Gram-negative bacteria continue to be a major problem for hospitalised patients,” commented Amanda Paschke, senior principal scientist, infectious disease clinical research, at Merck Research Laboratories.

GSK and Gilead join global efforts to tackle novel coronavirus

Last week,   Johnson &Johnson also said it has begun the development of a vaccine for the coronavirus, as well as providing 50 boxes containing tools for laboratory-based investigations to the

Will biosimilars ever catch on in the US?

The latest example involved Endo Pharmaceuticals paying Impax Laboratories $112m to delay selling a generic version of Opana ER.

J&J begins search for a coronavirus vaccine as confirmed cases rise

J&J has also provided 50 boxes containing tools for laboratory-based investigations to the Chinese Center for Disease Control and Prevention, which includes drug-screening for antiviral properties against

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]